4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride

C27H21ClF3N7O — CID 142785648

IUPAC4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride
SMILESCc1cn(-c2cc(N(c3ccc(C(N)=O)cc3)c3nccc(-c4cccnc4)n3)cc(C(F)(F)F)c2)cn1.Cl
InChIInChI=1S/C27H20F3N7O.ClH/c1-17-15-36(16-34-17)22-11-20(27(28,29)30)12-23(13-22)37(21-6-4-18(5-7-21)25(31)38)26-33-10-8-24(35-26)19-3-2-9-32-14-19;/h2-16H,1H3,(H2,31,38);1H
InChIKeyYDNCDWRPCCIKBU-UHFFFAOYSA-N
MW551.96 g/mol
LogP6.04
Rot. Bonds6

About 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride

4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride (PubChem CID 142785648) has the molecular formula C27H21ClF3N7O and a molecular weight of 551.96 g/mol. Its IUPAC name is 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride.

Molecular Properties

Compound Name4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride
PubChem CID142785648
Molecular FormulaC27H21ClF3N7O
Molecular Weight551.96 g/mol
Exact Mass551.14
IUPAC Name4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride
SMILESCc1cn(-c2cc(N(c3ccc(C(N)=O)cc3)c3nccc(-c4cccnc4)n3)cc(C(F)(F)F)c2)cn1.Cl
InChIInChI=1S/C27H20F3N7O.ClH/c1-17-15-36(16-34-17)22-11-20(27(28,29)30)12-23(13-22)37(21-6-4-18(5-7-21)25(31)38)26-33-10-8-24(35-26)19-3-2-9-32-14-19;/h2-16H,1H3,(H2,31,38);1H
InChIKeyYDNCDWRPCCIKBU-UHFFFAOYSA-N
XLogP6.04
TPSA102.82 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500551.96
LogP ≤ 56.04
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride?
The IUPAC name of 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride (CID 142785648) is 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride.
What is the SMILES notation for 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride?
The canonical SMILES for 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride is Cc1cn(-c2cc(N(c3ccc(C(N)=O)cc3)c3nccc(-c4cccnc4)n3)cc(C(F)(F)F)c2)cn1.Cl.
What is the InChIKey of 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride?
The InChIKey is YDNCDWRPCCIKBU-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H20F3N7O.ClH/c1-17-15-36(16-34-17)22-11-20(27(28,29)30)12-23(13-22)37(21-6-4-18(5-7-21)25(31)38)26-33-10-8-24(35-26)19-3-2-9-32-14-19;/h2-16H,1H3,(H2,31,38);1H.
What are the key properties of 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride?
4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride has a molecular weight of 551.96 g/mol, XLogP of 6.04, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-(4-methylimidazol-1-yl)-N-(4-pyridin-3-ylpyrimidin-2-yl)-5-(trifluoromethyl)anilino]benzamide;hydrochloride is sourced from PubChem (CID 142785648), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).